Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Cellular and Molecular Medicine
|
November 7, 2020
Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes
Sandra Mignot, Nicolas Cagnard, Benoit Albaud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 13, 2024
Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network
Sandrine Meunier, Annie Harroche, Antoine Rauch, et al.
Leukemia Research
|
August 15, 2015
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes
Cécile Bally, Aline Renneville, Claude Preudhomme, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 21, 2022
Emicizumab does not interfere with the activated clotting time
Ladislas Capdevila, Corinne Frère, Maximilien Desvages, et al.
Thrombosis and Haemostasis
|
June 11, 2025
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in France
Claire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes, et al.
Thrombosis Research
|
August 15, 2025
Is primary hemostasis involved in bleeding diathesis in patients with type 1 glycogen storage disease?
Floriane Devaux, Claire Auditeau, Cécile Bally, et al.
Nature Communications
|
May 26, 2018
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
Jacqueline Lehmann-Che, Cécile Bally, Eric Letouzé, et al.
Research and Practice in Thrombosis and Haemostasis
|
March 9, 2026
Platelet dense granule defect: experience in the French population
Delphine Borgel, Agathe Beauvais, Cécile Bally, et al.
Haematologica
|
February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Marie Sébert, Aline Renneville, Cécile Bally, et al.
Clinical and Experimental Rheumatology
|
May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study
Marie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Cellular and Molecular Medicine
|
November 7, 2020
Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes
Sandra Mignot, Nicolas Cagnard, Benoit Albaud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 13, 2024
Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network
Sandrine Meunier, Annie Harroche, Antoine Rauch, et al.
Leukemia Research
|
August 15, 2015
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes
Cécile Bally, Aline Renneville, Claude Preudhomme, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 21, 2022
Emicizumab does not interfere with the activated clotting time
Ladislas Capdevila, Corinne Frère, Maximilien Desvages, et al.
Thrombosis and Haemostasis
|
June 11, 2025
Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in France
Claire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes, et al.
Thrombosis Research
|
August 15, 2025
Is primary hemostasis involved in bleeding diathesis in patients with type 1 glycogen storage disease?
Floriane Devaux, Claire Auditeau, Cécile Bally, et al.
Nature Communications
|
May 26, 2018
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
Jacqueline Lehmann-Che, Cécile Bally, Eric Letouzé, et al.
Research and Practice in Thrombosis and Haemostasis
|
March 9, 2026
Platelet dense granule defect: experience in the French population
Delphine Borgel, Agathe Beauvais, Cécile Bally, et al.
Haematologica
|
February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Marie Sébert, Aline Renneville, Cécile Bally, et al.
Clinical and Experimental Rheumatology
|
May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study
Marie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Page
of 1